RETRACTED: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RETRACTED: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma

Published:2020-06 Issue: Volume:479 Page:1-12
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ding Chenyu,Yi Xuehan,Wu Xiyue,Bu Xingyao,Wang Desheng,Wu Zanyi,Zhang Gaoqi,Gu Jianjun,Dezhi Kang

Funder

Special Health Fund of Fujian Provincial Department of Finance

Fujian Medical University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. Glioma;Weller;Nat Rev Dis Primers,2015

2. Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience;Youland;J. Neuro Oncol.,2017

3. Optimal role of temozolomide in the treatment of malignant gliomas;Stupp;Curr. Neurol. Neurosci. Rep.,2005

4. Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain;Oliva;J. Biol. Chem.,2010

5. Temozolomide resistance in glioblastoma multiforme;Lee;Genes Dis,2016

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways;Non-coding RNA Research;2024-12

2. Circular RNA NFIX Functions as an Oncogene in Non‐Small Cell Lung Cancer by Modulating the miR‐214‐3p/TRIAP1 Axis;The Clinical Respiratory Journal;2024-08

3. Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis;Hematology;2024-07-26

4. The diagnostic value of blood miR-132-3p level in patients with Alzheimer's disease;2024-06-07

5. From bench to bedside: The promising value of exosomes in precision medicine for CNS tumors;Heliyon;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3